semaglutide clinical trials The US Department of Veterans Affairs has launched a new trial to determine if could be used to treat alcohol abuse. 600 veterans with moderate to severe alcohol abuse disorder Clinical Trials Overview Semaglutide Molecule

Phase 2 Obesity Trial The Phase 2 obesity trial published in the New England Journal of Medicine in 2023 randomized 338 adults without diabetes to receive Retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks

Female Fertility and Environmental Pollution

These medications mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which helps manage blood sugar levels by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying

Supporting this mechanistic role, observational studies indicate that initial carnitine uptake and serum L-carnitine levels in preterm infants during the early postnatal weeks are independently associated with brain size